Your basket is currently empty!
Barrier to a Cure: Limited Eligibility for Alzheimer’s Patients
Reading Time: 4 minutesIn a surprising twist, many Alzheimer’s patients are unable to access promising new treatments due to strict eligibility rules. These new treatments, such as lecanemab and aducanumab, use monoclonal antibodies to tackle the amyloid-ß deposits in the brain. However, only a small number of early-stage patients qualify for these clinical trials. Having…
Diagnostic Pathways: How to Obtain an ADHD Diagnosis in the UK
Reading Time: 5 minutesNavigating the labyrinth of ADHD diagnosis in the UK can be daunting. This article elucidates the process, highlighting key steps and potential challenges encountered along the way. The significance of accurate diagnosis is examined, followed by a discussion on post-diagnosis support and resources available within the UK. This comprehensive guide provides valuable…
